Docoh
Loading...

VICP Vicapsys Life Sciences

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

20 Sep 21
26 Oct 21
Quarter (USD)
Jun 21 Mar 21 Dec 20 Sep 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 170.62K 170.62K 170.62K 170.62K 170.62K 170.62K
Cash burn (monthly) (positive/no burn) (positive/no burn) 24.02K 15.97K 23.28K 12.03K
Cash used (since last report) n/a n/a 93.21K 61.96K 90.34K 46.68K
Cash remaining n/a n/a 77.41K 108.66K 80.29K 123.94K
Runway (months of cash) n/a n/a 3.2 6.8 3.4 10.3

Beta Read what these cash burn values mean

Financial report summary

?
Competition
Evotec SESernova
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: Cover, embedded, Inline, Memorandum, Page, PPM
Removed: April, reconciliation

Proxies

No filings